" It will take time for Lympho to go global, to expand to more cancers, to gain share." - tonoos
You know... in several more months we'll start discussing sales results, sales expectations, etc.
Management was reluctant to provide guidance with the Gamma hardware line. I can understand that, because big ticket items with long sales cycles can be difficult to predict.
But Lymphoseek is different. After sales reach a point where they stabilize and growth becomes predictable I wonder if management will begin providing guidance... the street will expect it, and institutional owners will want it. If we're gonna play with the big boys we'll need guidance. Knowing our new CEO I bet they will lean toward low-balling the guidance then beating the street. At least I hope so...
That'll make for interesting debates here. Quarterly revenues and earnings were never much of a focus in the past...
DDbuyer
